These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16612837)

  • 21. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome.
    Cheng J
    Biometrics; 2009 Mar; 65(1):96-103. PubMed ID: 18373714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional regression analysis using an F test for longitudinal data with large numbers of repeated measures.
    Yang X; Shen Q; Xu H; Shoptaw S
    Stat Med; 2007 Mar; 26(7):1552-66. PubMed ID: 16817228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating the accuracy of psychological scales using longitudinal data.
    Rutter CM; Miglioretti DL
    Biostatistics; 2003 Jan; 4(1):97-107. PubMed ID: 12925332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multivariate time-to-event analysis of multiple adverse events of drugs in integrated analyses.
    Güttner A; Kübler J; Pigeot I
    Stat Med; 2007 Mar; 26(7):1518-31. PubMed ID: 16903003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
    Mahaffey KW; Yang Q; Pieper KS; Antman EM; White HD; Goodman SG; Cohen M; Kleiman NS; Langer A; Aylward PE; Col JJ; Reist C; Ferguson JJ; Califf RM;
    J Gen Intern Med; 2008 Mar; 23(3):310-6. PubMed ID: 18196350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principal stratification with predictors of compliance for randomized trials with 2 active treatments.
    Roy J; Hogan JW; Marcus BH
    Biostatistics; 2008 Apr; 9(2):277-89. PubMed ID: 17681993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical methods for active extension trials.
    Hu Z; Follmann D
    Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes.
    Williams MM; Clouse RE; Nix BD; Rubin EH; Sayuk GS; McGill JB; Gelenberg AJ; Ciechanowski PS; Hirsch IB; Lustman PJ
    Diabetes Care; 2007 Apr; 30(4):801-6. PubMed ID: 17392541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A modified pseudolikelihood approach for analysis of longitudinal data.
    Wang YG; Zhao Y
    Biometrics; 2007 Sep; 63(3):681-9. PubMed ID: 17825002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
    Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reformulating the hazard ratio to enhance communication with clinical investigators.
    Moser BK; McCann MH
    Clin Trials; 2008; 5(3):248-52. PubMed ID: 18559414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements.
    Lui KJ
    Stat Med; 2007 Jul; 26(16):3140-56. PubMed ID: 17177272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The proportional odds model for multivariate interval-censored failure time data.
    Chen MH; Tong X; Sun J
    Stat Med; 2007 Dec; 26(28):5147-61. PubMed ID: 17476643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression.
    Janssen J; Hulshoff Pol HE; Schnack HG; Kok RM; Lampe IK; de Leeuw FE; Kahn RS; Heeren TJ
    Int J Geriatr Psychiatry; 2007 May; 22(5):468-74. PubMed ID: 17357181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
    Trivedi MH; Lin EH; Katon WJ
    CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating disease prevalence in two-phase studies.
    Alonzo TA; Pepe MS; Lumley T
    Biostatistics; 2003 Apr; 4(2):313-26. PubMed ID: 12925524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The art of clinical management in pharmacologic trials with depressed elderly patients: lessons from the Pittsburgh Study of Maintenance Therapies in Late-Life Depression.
    Miller MD; Frank E; Reynolds CF
    Am J Geriatr Psychiatry; 1999; 7(3):228-34. PubMed ID: 10438694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A local influence approach applied to binary data from a psychiatric study.
    Jansen I; Molenberghs G; Aerts M; Thijs H; Van Steen K
    Biometrics; 2003 Jun; 59(2):410-9. PubMed ID: 12926726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.